BRIEF-Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Reuters10-23

BRIEF-<a href="https://laohu8.com/S/SILO">Silo Pharma</a> Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Oct 23 (Reuters) - Silo Pharma Inc SILO.O:

SILO PHARMA ISSUES UPDATE ON MILESTONE ACHIEVEMENTS IN PTSD DRUG DEVELOPMENT AND NEW DIGITAL ASSETS TREASURY PROGRAM
SILO PHARMA INC - PREPARATION FOR FDA IND APPLICATION TO COMMENCE BEFORE YEAR-END

Source text: ID:nGNX6hrXkH

Further company coverage: SILO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2577302397?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 20:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577302397","market":"nz","top_or_hot":-1,"title":"BRIEF-Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/SILO\">Silo Pharma</a> Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program</title></head><body><p><span>Oct 23 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SILOD\">Silo Pharma</a> Inc <span>SILO.O</span>:</p><ul><li><p>SILO PHARMA ISSUES UPDATE ON MILESTONE ACHIEVEMENTS IN PTSD DRUG DEVELOPMENT AND NEW DIGITAL ASSETS TREASURY PROGRAM</p></li><li><p>SILO PHARMA INC - PREPARATION FOR FDA IND APPLICATION TO COMMENCE BEFORE YEAR-END</p></li></ul><p>Source text: <span>ID:nGNX6hrXkH</span></p><p>Further company coverage: <span>SILO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-23 20:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/SILO\">Silo Pharma</a> Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program</title></head><body><p><span>Oct 23 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SILOD\">Silo Pharma</a> Inc <span>SILO.O</span>:</p><ul><li><p>SILO PHARMA ISSUES UPDATE ON MILESTONE ACHIEVEMENTS IN PTSD DRUG DEVELOPMENT AND NEW DIGITAL ASSETS TREASURY PROGRAM</p></li><li><p>SILO PHARMA INC - PREPARATION FOR FDA IND APPLICATION TO COMMENCE BEFORE YEAR-END</p></li></ul><p>Source text: <span>ID:nGNX6hrXkH</span></p><p>Further company coverage: <span>SILO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4202","symbol_name":"服装、服饰与奢侈品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUAC7MCTB:1","article_id":"2577302397","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577302397","pubTimestamp":1761223785,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury ProgramOct 23 (Reuters) - Silo Pharma Inc SILO.O:SILO PHARMA ISSUES UPDATE ON MILESTO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4202":"服装、服饰与奢侈品","SILO":"SILO PHARMA INC.","BK4139":"生物科技"},"translate_title":"简介-Silo Pharma发布PTSD药物开发和新数字资产金库计划里程碑成就的最新消息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SILO":0.9},"content_text":"BRIEF-Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury ProgramOct 23 (Reuters) - Silo Pharma Inc SILO.O:SILO PHARMA ISSUES UPDATE ON MILESTONE ACHIEVEMENTS IN PTSD DRUG DEVELOPMENT AND NEW DIGITAL ASSETS TREASURY PROGRAMSILO PHARMA INC - PREPARATION FOR FDA IND APPLICATION TO COMMENCE BEFORE YEAR-ENDSource text: ID:nGNX6hrXkHFurther company coverage: SILO.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577302397","isCrawlerRequest":true}